您搜索了: glikoprote (拉脱维亚语 - 英语)

olanzap ns galvenok rt saist s ar album nu un α1 sk bo glikoprote nu.
olanzapine is bound predominantly to albumin and α 1-acid-glycoprotein.

t d noz m ga mijiedarb ba ar citiem p- glikoprote na inhibitoriem nav gaid ma.
therefore, meaningful interactions would not be expected with other p-glycoprotein inhibitors.

p t jumi in vitro liecin ja, ka sitaglipt ns ir p- glikoprote na un oat3 substr ts.
in vitro transport studies showed that sitagliptin is a substrate for p-glycoprotein and oat3.

sitaglipt ns ir ar p- glikoprote na substr ts, kas ar var b t iesaist ts sitaglipt na ren las elimin cijas medi šan.
sitagliptin is also a substrate of p-glycoprotein, which may also be involved in mediating the renal elimination of sitagliptin.

sitaglipt nam ir neliela ietekme uz digoks na koncentr ciju plazm, un in vivo tas var tu b t v jš p- glikoprote na inhibitors.
sitagliptin had a small effect on plasma digoxin concentrations, and may be a mild inhibitor of p- glycoprotein in vivo.

kl nisk p t jum sitaglipt ns nedaudz ietekm ja digos na plazmas koncentr ciju, kas liecina, ka sitaglipt ns var tu b t m rens p- glikoprote na inhibitors.
in a clinical study sitagliptin had a small effect on plasma digoxin concentrations indicating that sitagliptin may be a mild inhibitor of p-glycoprotein.

ciklospor ns: p t jums tika veikts, lai nov rt tu ciklospor na, sp c ga p- glikoprote na inhibitora, ietekmi uz sitaglipt na farmakokin tiku.
a study was conducted to assess the effect of cyclosporine, a potent inhibitor of p-glycoprotein, on the pharmacokinetics of sitagliptin.

in vitro pie terapeitiski noz m gas plazmas koncentr cijas sitaglipt ns neinhib ja oat3 (ic50=160 µg) vai p - glikoprote na (l dz 250 µm) medi to transportu.
in vitro, sitagliptin did not inhibit oat3 (ic50=160 μ m) or p-glycoprotein (up to 250 μ m) mediated transport at therapeutically relevant plasma concentrations.